27
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Detection of Pulmonary Embolism in Returning Travelers with Hypoxemic Pneumonia due to COVID-19 in Reunion Island

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract.

          The aim of this study was to evaluate the occurrence of pulmonary embolism in returning travelers with hypoxemic pneumonia due to COVID-19. All returning travelers to Reunion Island with hypoxemic pneumonia due to COVID-19 underwent computed tomography pulmonary angiography (CTPA) and were included in the cohort. Thirty-five patients were returning travelers with hypoxemic pneumonia due to COVID-19 and had recently returned from one of the countries most affected by the COVID-19 outbreak (mainly from France and Comoros archipelago). Five patients (14.3%) were found to have pulmonary embolism and two (5.9%) were incidentally found to have deep vein thrombosis on CTPA. Patients with pulmonary embolism or deep vein thrombosis had higher D-dimer levels than those without pulmonary embolism or deep vein thrombosis ( P = 0.04). Returning travelers with hypoxemic pneumonia due to COVID-19 should be systematically screened for pulmonary embolism.

          Related collections

          Most cited references8

          • Record: found
          • Abstract: found
          • Article: not found

          Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

          Abstract Background Three months ago, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) broke out in Wuhan, China, and spread rapidly around the world. Severe novel coronavirus pneumonia (NCP) patients have abnormal blood coagulation function, but their venous thromboembolism (VTE) prevalence is still rarely mentioned. Objectives To determine the incidence of VTE in patients with severe NCP. Methods In this study, 81 severe NCP patients in the intensive care unit (ICU) of Union Hospital (Wuhan, China) were enrolled. The results of conventional coagulation parameters and lower limb vein ultrasonography of these patients were retrospectively collected and analyzed. Results The incidence of VTE in these patients was 25% (20/81), of which 8 patients with VTE events died. The VTE group was different from the non‐VTE group in age, lymphocyte counts, activated partial thromboplastin time (APTT), D‐dimer, etc. If 1.5 µg/mL was used as the D‐dimer cut‐off value to predicting VTE, the sensitivity was 85.0%, the specificity was 88.5%, and the negative predictive value (NPV) was 94.7%. Conclusions The incidence of VTE in patients with severe NCP is 25% (20/81), which may be related to poor prognosis. The significant increase of D‐dimer in severe NCP patients is a good index for identifying high‐risk groups of VTE.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020

            A novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) causing a cluster of respiratory infections (coronavirus disease 2019, COVID-19) in Wuhan, China, was identified on 7 January 2020. The epidemic quickly disseminated from Wuhan and as at 12 February 2020, 45,179 cases have been confirmed in 25 countries, including 1,116 deaths. Strengthened surveillance was implemented in France on 10 January 2020 in order to identify imported cases early and prevent secondary transmission. Three categories of risk exposure and follow-up procedure were defined for contacts. Three cases of COVID-19 were confirmed on 24 January, the first cases in Europe. Contact tracing was immediately initiated. Five contacts were evaluated as at low risk of exposure and 18 at moderate/high risk. As at 12 February 2020, two cases have been discharged and the third one remains symptomatic with a persistent cough, and no secondary transmission has been identified. Effective collaboration between all parties involved in the surveillance and response to emerging threats is required to detect imported cases early and to implement adequate control measures.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2

              Severe coronavirus disease 2019 (COVID-19) is commonly complicated with coagulopathy, the difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 has not been analyzed. Coagulation results and clinical features of consecutive patients with severe pneumonia induced by SARS-CoV2 (COVID group) and non-SARS-CoV2 (non-COVID group) in Tongji hospital were retrospectively analyzed and compared. Whether patients with elevated D-dimer could benefit from anticoagulant treatment was evaluated. There were 449 COVID patients and 104 non-COVID patients enrolled into the study. The 28-day mortality in COVID group was approximately twofold of mortality in non-COVID group (29.8% vs. 15.4%, P = 0.003), COVID group were older (65.1 ± 12.0 vs. 58.4 ± 18.0, years, P   3.0 μg/mL (32.8% vs. 52.4%, P = 0.017). Patients with severe pneumonia induced by SARS-CoV2 had higher platelet count than those induced by non-SARS-CoV2, and only the former with markedly elevated D-dimer may benefit from anticoagulant treatment.
                Bookmark

                Author and article information

                Journal
                Am J Trop Med Hyg
                Am. J. Trop. Med. Hyg
                tpmd
                tropmed
                The American Journal of Tropical Medicine and Hygiene
                The American Society of Tropical Medicine and Hygiene
                0002-9637
                1476-1645
                August 2020
                1 July 2020
                1 July 2020
                : 103
                : 2
                : 844-846
                Affiliations
                [1 ]Pneumologie, Centre Hospitalier Universitaire Felix Guyon Allée des Topazes, Saint Denis, France;
                [2 ]Radiologie, Centre Hospitalier Universitaire Felix Guyon Allée des Topazes, Saint Denis, France;
                [3 ]Réanimation Polyvalente, Centre Hospitalier Universitaire Felix Guyon Allée des Topazes, Saint Denis, France;
                [4 ]INSERM CIC 1410 Clinical and Epidemiology, University Hospital, Saint Denis, France;
                [5 ]Department of Public Health and Research Support, Methodological Support and Biostatistics Unit, University Hospital, Saint Denis, France;
                [6 ]Service des Maladies Infectieuses, Centre Hospitalier Universitaire Felix Guyon Allée des Topazes, Saint Denis, France
                Author notes
                [* ]Address correspondence to Nicolas Allou, Réanimation Polyvalente, Centre Hospitalier Universitaire Félix Guyon, Allée des Topazes, Saint-Denis 97405, France. E-mail: nicolas.allou@ 123456hotmail.fr

                Disclosure: The present observational study was approved by the Ethics Committee of Infectious Disease and Tropical Medicine (CER-MIT) and was declared to the Commission nationale de l’informatique et des libertés (French Data Protection Agency or CNIL MR004, N° 2206739). The need for informed consent was waived, as the study was non-interventional and followed our usual protocol. The dataset used in the current study are available from the corresponding author on reasonable request.

                Financial support: This work was internally funded.

                Authors’ addresses: Kevin Larsen, Nathalie Coolen-Allou, Laurie Masse, Michel André, and Emilie Foch, Pneumologie, Centre Hospitalier Universitaire Felix Guyon Allée des Topazes, Saint Denis, France, E-mails: kevin.larsen0511@ 123456gmail.com , nathalie.allou@ 123456chu-reunion.fr , laurie.masse@ 123456chu-reunion.fr , michel.andre@ 123456chu-reunion.fr , and emilie.foch@ 123456chu-reunion.fr . Alexandre Angelino, Jérôme Allyn, Thierry Vitry, Jean Yves Travers, and Nicolas Allou, Réanimation Polyvalente, Centre Hospitalier Universitaire Felix Guyon, Saint Denis, France, E-mails: dinosangelino@ 123456gmail.com , jerome.allyn@ 123456chu-reunion.fr , thierry.vitry@ 123456chu-reunion.fr , jean-yves.travers@ 123456chu-reunion.fr , and nicolas.allou@ 123456hotmail.fr . Lea Bruneau and Adrien Maillot, Epidemiologie, Centre Hospitalier Universitaire Felix Guyon, Saint Denis, France, E-mails: lea.bruneau@ 123456chureunion.fr and adrien.maillot@ 123456chureunion.fr . Marie Lagrange-Xelot, Service des Maladies Infectieuses, Centre Hospitalier Universitaire Felix Guyon Allée des Topazes, Saint Denis, France, E-mail: marie.lagrange@ 123456chu-reunion.fr .

                Article
                tpmd200597
                10.4269/ajtmh.20-0597
                7410458
                32618261
                34c08360-ce77-4ade-bc27-4479284caa59
                © The American Society of Tropical Medicine and Hygiene

                This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 05 June 2020
                : 24 June 2020
                Page count
                Pages: 3
                Categories
                Articles

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article